Sm. Ametamey et al., RADIOSYNTHESIS OF [C-11] BROFAROMINE, A POTENTIAL TRACER FOR IMAGING MONOAMINE-OXIDASE-A, Nuclear medicine and biology, 23(3), 1996, pp. 229-234
-5(-methoxy-7-bromobenzofuranyl)-2-piperidine-HCl) is a potent and sel
ective inhibitor of monoamine oxidase (MAO) A. Two methods for its syn
thesis and a preliminary positron emission tomography (PET) evaluation
in monkey brain are described. The first method, at low carrier conce
ntration of CO2, consisted of direct O-methylation of (4-(5-hydroxy-7-
bromobenzofuranyl) 2-piperidine). The total radiochemical yield achiev
ed ranged from 30 to 50% (from end of bombardment [EOB] and decay corr
ected) with an overall synthesis time of 45 min, The second approach,
with high carrier amounts of CO2 arising from inherent target problems
, was accomplished in a three-step route involving protection of secon
dary amino functionality, O-methylation and deprotection. The total ra
diochemical yield was 10% (from EOB and decay corrected) with a total
synthesis time of 70 min, For both methods methylation was achieved us
ing the classical methylating agent [C-11]CH3I, and radiochemical puri
ty was higher than 98%. PET evaluation of the radioligand in a Rhesus
monkey showed a high uptake of radioactivity in the brain. Using the i
rreversible MAO-A inhibitor clorgyline and reversible MAO-A inhibitors
moclobemide and brofaromine, three blockade experiments were designed
to determine the extent of specific binding of [C-11]brofaromine to M
AO-A. No apparent decrease in accumulation of radioactivity in the mon
key brain was observed when compared to a baseline scan.